These results indicate that Ad-IL-12/GPC3 combined immunization promotes the increase and maturation of CD11c+ and CD8+CD11c+ DC subset in the HCC tumor model (Figure 3E,F). Here, ITGAX is linked to hepatocellular carcinoma.